Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,650 | -$115,088 | -$90,137 | -$89,860 |
| Dep. & Amort. | $255 | $280 | $364 | $479 |
| Deferred Tax | $0 | $2 | -$142 | -$897 |
| Stock-Based Comp. | $4,030 | $10,264 | $8,060 | $6,466 |
| Change in WC | -$7,426 | -$3,405 | -$3,963 | $3,701 |
| Other Non-Cash | -$817 | $41,647 | $1,506 | $1,366 |
| Operating Cash Flow | -$43,608 | -$66,300 | -$84,312 | -$78,745 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$133 | -$147 | -$61 | -$7 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$57,059 | -$153,227 |
| Inv. Sales/Matur. | $0 | $8,000 | $146,080 | $142,450 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$133 | $7,853 | $88,960 | -$10,784 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,639 | $10,664 | $40,861 | $97,686 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $16 | $4 | $1,200 | $1,222 |
| Financing Cash Flow | $9,655 | $10,668 | $42,061 | $98,908 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$34,086 | -$47,779 | $46,709 | $9,379 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59,807 | $107,586 | $60,877 | $51,498 |
| End Cash | $25,721 | $59,807 | $107,586 | $60,877 |
| Free Cash Flow | -$43,741 | -$66,447 | -$84,373 | -$78,752 |